Genomic Causes of Co-Morbidity in Epilepsy
Author Information
Author(s): Kasperavičiūtė Dalia, Catarino Claudia B., Chinthapalli Krishna, Clayton Lisa M. S., Thom Maria, Martinian Lillian, Cohen Hannah, Adalat Shazia, Bockenhauer Detlef, Pope Simon A., Lench Nicholas, Koltzenburg Martin, Duncan John S., Hammond Peter, Hennekam Raoul C. M., Land John M., Sisodiya Sanjay M.
Primary Institution: University College London Institute of Neurology
Hypothesis
Can genomic microdeletions explain co-morbidities in patients with epilepsy?
Conclusion
Co-morbidities in patients with epilepsy can be part of a genomic abnormality even in the absence of known congenital malformations or intellectual disabilities.
Supporting Evidence
- Genomic microdeletions were found in three patients with epilepsy.
- Gene-driven investigations revealed clinically significant unsuspected conditions.
- Co-morbidities were previously considered unrelated to epilepsy.
Takeaway
Some people with epilepsy also have other health problems that can be linked to their genes. This study found that looking at their genes helped explain these extra problems.
Methodology
The study involved detailed gene-driven clinical investigations and genetic testing of three patients with sporadic epilepsy and identified large genomic microdeletions.
Limitations
The study is not a systematic survey and only selected patients based on specific criteria.
Participant Demographics
Three patients with sporadic, non-syndromic epilepsies, including two females and one male, aged 26, 44, and 31.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website